toggle visibility Search & Display Options

Select All    Deselect All
 |   | 
Details
   print
  Record Links
Author (up) Fortes, R.C.; Novaes, M.R.C.G.; Recova, V.L.; Melo, A.L. url  doi
openurl 
  Title Immunological, hematological, and glycemia effects of dietary supplementation with Agaricus sylvaticus on patients' colorectal cancer Type Journal Article
  Year 2009 Publication Experimental Biology and Medicine (Maywood, N.J.) Abbreviated Journal Exp Biol Med (Maywood)  
  Volume 234 Issue 1 Pages 53-62  
  Keywords  
  Abstract OBJECTIVE: The aim of this study was to evaluate the effects of dietary supplementation with Agaricus sylvaticus fungus on hematological, immunological, and glycemia levels of postsurgical patients with colorectal cancer. METHODS: A randomized, placebo-controlled, clinical trial was conducted at the General Hospital of Brazil for 6 months. Fifty-six patients with colorectal cancer (stages I, II, and III) were divided into 2 groups: A. sylvaticus (30 mg/kg/day) and placebo. Complete hemogram, serum iron, and fasting glycemia evaluations were carried out throughout the treatment course. Subjects were divided according to body mass index (BMI), sex, and stage of colorectal cancer. Data were analyzed using SPSS 14.0 programs, Student's t test, and F statistical test, with P < or = 0.05 considered significant. RESULTS: After 6 months of supplementation, the group that received A. sylvaticus showed significant increases in hemoglobin (P = 0.0001), hematocrit (P = 0.0001), erythrocytes (P = 0.01), mean cell volume (P = 0.01), mean cell hemoglobin (P = 0.0001), mean cell hemoglobin concentration (P = 0.0001), and neutrophil levels (P = 0.0001). The platelet count was significantly reduced (P = 0.03), but remained within normal levels. No significant alterations were observed in the placebo group. The study group was composed of 32 women (57.1%) and 24 men (42.9%). Mean BMI was 24.65 kg/m2. Glycemia levels in the placebo group (average age 59.14 +/- 12.95 years) were: initial, 94.36 +/- 15.34 mg/dl; 3 months, 98.12 +/- 15.54 mg/dl (P = 0.03); and 6 months, 98.52 +/- 9.03 mg/dl (P = 0.01). Glycemia levels in the supplemented group (average age 56.34 +/- 15.53 years) were: initial, 95.92 +/- 11.64 mg/dl, 3 months, 94.88 +/- 12.24 mg/dl (P = 0.65); and 6 months, 92.86 +/- 6.82 mg/dl (P = 0.01). CONCLUSIONS: The results of this study suggest that supplementation with A. sylvaticus produces benefits in hematological and immunological parameters and can reduce glycemia levels in patients with colorectal cancer.  
  Address Human Nutrition, Science and Education School, Sena Aires-GO/ University of Brasilia-DF, Brazil. renatacfortes@yahoo.com.br  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 1535-3702 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:18997106 Approved no  
  Call Number refbase @ user @ Serial 136  
Permanent link to this record
Select All    Deselect All
 |   | 
Details
   print

Save Citations:
Export Records: